Helping Affected Groups Fight the Opioid Epidemic
Millions of Americans have been hurt by dangerous highly addictive prescription opioids. The Bramzon Law Firm PLLC expert legal team is fighting for justice on behalf of individuals, municipalities, Native American tribes, and other minority groups. Contact us today, we can help.
The $35 million settlement.
Mallinckrodt Pharmaceuticals and The Justice Department concluded to a $35 million settlement that resolved allegations that Mallinckrodt did not report a very large quantity of oxycodone. The extremely addictive pills were found on the black market in Florida, where they fueled the deadly opioid epidemic.
The agreement is the first with a major manufacturer of the opioids that have sparked a crisis of overdoses and addictions across the country. The Justice Department said the deal establishes “groundbreaking” new standards that require the company to track its drugs as they flow through the supply chain to consumers in an effort to control the epidemic. You can read the full story here.
Today, many victims have filed lawsuits against physicians and drug manufacturers for failing to state the addictiveness of the pills. If you or a loved one are addicted to prescription painkillers, simply contact us today for legal consultation. You may be eligible for financial compensation for your pain.
In January 2017, America’s largest drug distributor—McKesson Corp.—agreed to pay $150 million to the U.S. government to settle Justice Department charges that it failed to detect and report suspicious opioid orders. This was the largest such fine in history.
In January 2017, Cardinal Health agreed to pay $44 million to three states—Florida, Maryland, and New York—to settle charges that it failed to report and rein in suspicious opioid orders in these states.
In May 2007, Purdue Pharma agreed to pay at least $600 million in fines after pleading guilty to understating the addictiveness of OxyContin. Purdue had marketed OxyContin as a “reduced-risk” narcotic from its FDA approval in 1995 until 2001 (when it dropped that label).
In December 2015, Purdue Pharma agreed to pay $24 million to the state of Kentucky to settle charges that it understated the addictiveness of OxyContin. State Attorney General Jack Conway said that the money would go to addiction prevention and rehabilitation programs.
In January 2017, Costco agreed to pay $11.75 million to the U.S. government to settle Justice Department charges that the company unlawfully filled prescriptions and failed to maintain accurate records with regard to prescription drugs.
In May 2008, McKesson Corp. agreed to pay $13.25 million to state attorney offices in Florida, Maryland, Colorado, Texas, Utah, and California to settle civil charges that three McKesson facilities failed to report suspicious orders of hydrocodone and alprazolam, particularly those placed online and given to customers without prescriptions.
THE SPREADING EPIDEMIC
SEEK LEGAL HELP
TAKE ACTION TODAY
Put our firm's litigation experience to work for you